Gerresheimer at Pharmapack 2024: Innovative solutions and expert presentations
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
Broad portfolio for biologics, including cell and gene therapy products Digitally connected Drug Delivery Devices for s…
BSI Life Sciences today announced biopharma Ocular Therapeutix (NASDAQ: OCUL) as its latest client to go live with its c…
With innovative, solution-oriented, and sustainable developments, the Gerresheimer team presents itself at Pharmapack an…
Edmund Optics®, a leading global manufacturer and supplier of optical components, announces the recipients of its 2022 E…
With DropControl, Gerresheimer has developed a new dropper insert for modern drugs with low viscosity for ophthalmology,…
On August 27, Gerresheimer Boleslawiec S.A. celebrates its 70th anniversary in Poland. Founded in 1952, the industrial p…
Gerresheimer ceremoniously took over a new building in Berlin, Ohio. In the future, the square plastic containers of the…
According to Future Market Insights (FMI), the demand for ocular drug delivery system is expected to rise considerably,…
Blow fill seal (BFS) technology is highly sought-after as a preferred packaging solution in pharmaceutical manufacturing…
In the pharmaceutical industry, counterfeiting has emerged as a major concern for manufacturers and consumers. Given th…